WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Ozempic and Wegovy linked to surprising drop in violent behavior

A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect how people act on impulses, though researchers stress that cause and effect have not been proven.

Raccontata dagizmodo.comhindustantimes.comsciencedaily.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
hindustantimes.com20 g fa

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

Leggi questa versione → originale
gizmodo.com21 g fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 29 maggio 2026·gizmodo.com

    Can Ozempic Treat Alcoholism? Here's What You Should Know

    A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

  2. sabato 30 maggio 2026·hindustantimes.com

    Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

    GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

sciencedaily.com19 g fa

People taking GLP-1 weight loss drugs like Ozempic started moving less

GLP-1 users (Ozempic, Wegovy) reduced activity despite weight loss: daily steps fell from 5,047 to 4,487, moderate-to-vigorous activity from 28 to 22 minutes. Since these drugs reduce muscle mass alongside fat, exercise intervention is essential—not optional—for protecting patient health outcomes.

Leggi questa versione → originale
  • lunedì 1 giugno 2026·sciencedaily.com

    Ozempic and Wegovy linked to surprising drop in violent behavior

    A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these…

  • lunedì 1 giugno 2026·sciencedaily.com

    People taking GLP-1 weight loss drugs like Ozempic started moving less

    People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…

  • lunedì 1 giugno 2026·sciencedaily.com

    Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

    A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…

  • lunedì 1 giugno 2026·sciencedaily.com

    Scientists discover why ozempic may not work for some people

    Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…